MapLight Therapeutics MPLT
NASDAQ MPLT
$7.44 +0.16 (+2.20%)
At close: Nov 10, 2026 · 4:00 PM EST

MapLight Therapeutics (MPLT) Common Equity (2024 - 2026)

Updated

MapLight Therapeutics (MPLT) recorded Common Equity of $348.3 million in Q2 2026, compared with -$245.06 million a year earlier.

Analysis

MapLight Therapeutics (MPLT) Common Equity (2024 - 2026) Analysis & Trends

At the end of FY2025, MapLight Therapeutics reported Common Equity of $458.37 million.

  • Across earlier years, Common Equity came in at -$193.63 million in FY2024.
  • Quarterly Common Equity has ranged from -$274.18 million in Q3 2025 to $458.37 million in Q4 2025 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 40.27 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 81.53 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -4.58 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 44.95 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 41.95 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 50.37 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 13.04 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 89.30 Bn
10 MapLight Therapeutics 340.28 Mn 340.28 Mn - 348.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 348.30 Mn
Dec 31, 2025 458.37 Mn
Sep 30, 2025 -274.18 Mn
Jun 30, 2025 -245.06 Mn
Dec 31, 2024 -193.63 Mn
Sep 30, 2024 -172.37 Mn
API Access

MapLight Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=MPLT&period=max&api_key=YOUR_API_KEY